Shanghai Shyndec Pharmaceutical Co., Ltd. (600420.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 8.26

From 52W high−27.09%

Volume7.42M

Market capCNY 11.33B

P/E (TTM)12.0x

P/S (TTM)1.2x

Div yield2.46%

Key dataSep 18, 2026

Open

CNY 8.26

From 52W high

−27.09%

Volume

7.42M

Market cap

CNY 11.33B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.6x

P/E (TTM)

12.0x

RSI (14)

32.7

MomentumView details →

1D Return

−0.12%

YTD Return

−19.50%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

12.0x

EV/EBITDA

4.6x

EV/Sales

1.1x

P/S (TTM)

1.2x

P/B (TTM)

0.8x

ProfitabilityView details →

Gross Margin

30.52%

Net Margin

8.15%

EBITDA Margin

23.09%

ROE (TTM)

5.16%

ROA (TTM)

3.69%

Asset Turnover

0.46x

GrowthView details →

Revenue YoY

−15.36%

EPS YoY

−35.48%

FCF YoY

−53.31%

Revenue CAGR 3Y

−10.27%

EPS CAGR 3Y

+4.72%

EBITDA YoY

—

MomentumView details →

1D Return

−0.12%

YTD Return

−19.50%

1Y Return

−25.14%

RSI (14)

32.7

vs 50D SMA

−5.82%

vs 200D SMA

−15.25%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

3.59x

Quick Ratio

3.01x

Div Yield

2.46%

Div Rate

CNY 0.20

Div Growth 1Y

+50.00%

EarningsView details →

EPS (Actual)

CNY 0.10

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

8.82B

Net Income (TTM)

718.59M

Op. CF (TTM)

1.03B

Latest newsMore news →

Sinopharm Modern Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for tacrolimus ointment in 0.03% and 0.1% strengths for moderate-to-severe atopic dermatitis.2d ago

China National Medicines Corporation Ltd. received a drug registration certificate approved and issued by the National Medical Products Administration for Brexpiprazole tablets, an oral atypical antipsychotic drug for the treatment of adult schizophrenia, specification 2mg, registration classification as chemical drug category 4, deemed to have passed consistency evaluation.23d ago

Similar companies

Consun Pharmaceutical Group Limited01681.HK Elanco Animal Health IncorporatedELAN 微芯生物688321.SH Ab&B Bio Tech Co Ltd.02627.HK 羚锐制药600285.SH Sunshine Lake Pharma Co., Ltd.06887.HK Find similar companies →

Latest newsMore news →

Sinopharm Modern Pharmaceutical received a drug registration certificate from China's National Medical Products Administration for tacrolimus ointment in 0.03% and 0.1% strengths for moderate-to-severe atopic dermatitis.2d ago China National Medicines Corporation Ltd. received a drug registration certificate approved and issued by the National Medical Products Administration for Brexpiprazole tablets, an oral atypical antipsychotic drug for the treatment of adult schizophrenia, specification 2mg, registration classification as chemical drug category 4, deemed to have passed consistency evaluation.23d ago